OMNIQ Corp. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q3 2025.
-
Symbol
-
OMQS on OTC
-
Location
-
Murray, UT
-
Fiscal year end
-
31 December
-
Latest financial report
-
14 Nov 2025
Quick Takeaways
- OMQS - OMNIQ Corp. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q3 2025.
- Headline metric: Return On Equity 2.8%.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-97%</span>.
- Most recent SEC facts end date: 04 Nov 2025.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2025-11-04) highlights Return On Equity 2.8%, Return On Assets -2.4%, and Operating Margin -7.9%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
38.9/100
Weak
Confidence high
Return On Equity
2.8%
Metric score 0.0/100
Return On Assets
-2.4%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.58x
- Quick Ratio
- 0.42x
- Debt to Equity
- -2.15x
Strengths
Revenues YoY and NetIncomeLoss YoY
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
2.8%
YoY: -97%
Industry median:
-0.88%
(n=54)
View history
Return On Assets
-2.4%
YoY: -96%
Industry median:
-8.2%
(n=54)
View history
Operating Margin
-7.9%
YoY: -81%
Industry median:
-4.2%
(n=42)
View history
Current Ratio
0.58x
YoY: +72%
Industry median:
1.43x
(n=60)
View history
Quick Ratio
0.42x
YoY: +70%
Industry median:
1.06x
(n=47)
View history
Debt-to-equity
-2.15x
YoY: +4.7%
Industry median:
0.44x
(n=51)
View history
Revenues YoY
42%
YoY:
Industry median:
-0.32%
(n=16)
View history
NetIncomeLoss YoY
53%
YoY:
Industry median:
-2.8%
(n=53)
View history
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0.58x
|
+72%
|
1.43x
(n=60)
|
Q3 2025
|
Q3 2025
|
x
|
|
Quick Ratio
|
0.42x
|
+70%
|
1.06x
(n=47)
|
Q3 2025
|
Q3 2025
|
x
|
|
Debt-to-equity
|
-2.15x
|
+4.7%
|
0.44x
(n=51)
|
Q3 2025
|
Q3 2025
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Revenues YoY
|
42%
|
|
-0.32%
(n=16)
|
Q3 2025
|
|
%
|
|
NetIncomeLoss YoY
|
53%
|
|
-2.8%
(n=53)
|
Q3 2025
|
Q3 2025
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
11,602,930
|
+8.3%
|
Q3 2025
|
Q3 2025
|
shares
|
|
Common Stock, Shares, Outstanding
|
11,602,930
|
+8.3%
|
Q3 2025
|
Q3 2025
|
shares
|
|
Common Stock, Value, Issued
|
$12,000
|
+9.1%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
11,505,104
|
+7.6%
|
Q3 2025
|
Q3 2025
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
11,505,104
|
+7.6%
|
Q3 2025
|
Q3 2025
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Revenue from Contract with Customer, Excluding Assessed Tax
|
$73,897,000
|
+42%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Research and Development Expense
|
$1,642,000
|
-20%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Operating Income (Loss)
|
$5,817,000
|
+73%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Nonoperating Income (Expense)
|
$938,000
|
+43%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
$4,879,000
|
+79%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Income Tax Expense (Benefit)
|
$120,000
|
|
Q3 2025
|
Q3 2025
|
USD
|
|
Earnings Per Share, Basic
|
0
|
+86%
|
Q3 2025
|
Q3 2025
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$679,000
|
-45%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Accounts Receivable, after Allowance for Credit Loss, Current
|
$10,579,000
|
-40%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Inventory, Net
|
$3,492,000
|
-38%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Other Assets, Current
|
$38,000
|
-5%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Assets, Current
|
$15,484,000
|
-39%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Property, Plant and Equipment, Net
|
$668,000
|
-21%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Operating Lease, Right-of-Use Asset
|
$371,000
|
-71%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Goodwill
|
$1,891,000
|
-34%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Other Assets, Noncurrent
|
$2,251,000
|
+24%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Assets
|
$25,020,000
|
-33%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Liabilities, Current
|
$26,751,000
|
-65%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Operating Lease, Liability, Noncurrent
|
$91,000
|
-82%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Other Liabilities, Noncurrent
|
$728,000
|
+45%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Liabilities
|
$38,100,000
|
-51%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Accumulated Other Comprehensive Income (Loss), Net of Tax
|
$723,000
|
-143%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$124,698,000
|
-3.4%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$13,080,000
|
+67%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Liabilities and Equity
|
$25,020,000
|
-33%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Common Stock, Shares Authorized
|
35,000,000
|
0%
|
Q3 2025
|
Q3 2025
|
shares
|
|
Common Stock, Shares, Issued
|
11,602,930
|
+8.3%
|
Q3 2025
|
Q3 2025
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0
|
0%
|
Q3 2025
|
Q3 2025
|
USD/shares
|
|
Depreciation
|
$17,000
|
-80%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
|
$576,000
|
+69%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Operating Lease, Liability, Current
|
$218,000
|
-71%
|
Q3 2025
|
Q3 2025
|
USD
|
|
Current Income Tax Expense (Benefit)
|
$120,000
|
|
Q3 2025
|
Q3 2025
|
USD
|
|
Additional Paid in Capital
|
$112,328,000
|
+43%
|
Q3 2025
|
Q3 2025
|
USD
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets